News

Great Ajax Corp. Reports Q3 2024 Financial Highlights

Great Ajax Corp. Reports Q3 2024 Financial Highlights

Great Ajax Corp. Reports Q3 2024 Financial Highlights

Great Ajax Corp. (NYSE: AJX) announced its financial results for the third quarter ended September 30, revealing a dynamic shift in its operational strategy. This period marks a challenging yet transformative phase for the company as it steers toward becoming a leader in opportunistic real estate investments.

Financial Overview

In the recently concluded quarter, the company reported a GAAP net loss attributable to common stockholders amounting to $(8.0) million, translating to $(0.18) per diluted share. The earnings available for distribution were $(5.4) million, or $(0.12) per diluted common share. As of September 30, 2024, the book value per common share stood at $5.47, and the company declared a common dividend of $2.7 million, equating to $0.06 per share.

Operational Highlights

During Q3, Great Ajax made significant strides in its operational goals. The key highlights from the quarter include:

  • Loan and Security Sales: The company successfully sold residential loans and securities approximating $148 million in unpaid principal balance (“UPB”), generating net proceeds of about $31.7 million.
  • Commercial Real Estate Investments: An acquisition of $81.9 million in UPB of commercial mortgage-backed securities (“CMBS”) was completed, enhancing its commitment to the commercial real estate sector, now totaling $101.9 million.
  • Capital Activity: The company filed a shelf registration with the U.S. Securities and Exchange Commission to increase the offering price of its securities to $400 million, preparing for future growth and expansion.
  • Dividend Announcement: A cash dividend of $0.06 per common share was declared by the board, to be paid to stockholders of record.

Rebranding Strategy

In conjunction with its evolving strategy, Great Ajax Corp. is set to undergo a rebranding, transitioning to Rithm Property Trust Inc. This initiative aligns with its strategic transaction with Rithm Capital Corp., emphasizing its dedication to becoming an opportunistic real estate investment platform. The name change is anticipated to be implemented in the fourth quarter of 2024.

Earnings Call and Future Outlook

Great Ajax will host an earnings conference call on October 21, 2024, at 8:00 AM ET, to delve into its financial outcomes for Q3. Investors and stakeholders are encouraged to participate and gain insights into the future direction of the company, especially its focus on commercial real estate investment.

About Great Ajax Corp.

Great Ajax Corp. operates as a real estate investment platform that acquires, invests in, and manages both re-performing and non-performing loans secured by residential and commercial properties. With plans to transition toward a flexible commercial real estate-focused investment strategy, the company aims to enhance its market position and create value for its shareholders. As part of its commitment, Great Ajax is organized as a real estate investment trust (REIT) and strives to maintain compliance with federal income tax obligations.

Frequently Asked Questions

What were Great Ajax Corp.'s financial results for Q3 2024?

The company reported a GAAP net loss of $(8.0) million, or $(0.18) per diluted share.

How much did Great Ajax Corp. declare in dividends?

The board declared a cash dividend of $0.06 per common share, totaling $2.7 million.

What is the significance of the rebranding?

The rebranding to Rithm Property Trust Inc. signals a strategic shift to become an opportunistic real estate investment platform.

When is the earnings conference call scheduled?

The earnings conference call is scheduled for October 21, 2024, at 8:00 AM ET.

What are the main focuses of Great Ajax Corp. moving forward?

The company aims to enhance its investments in the commercial real estate sector while continuing to manage re-performing loans.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles